Skip to content
Company Analysis

Tilray Brands, Inc. TLRY

A comprehensive view of key metrics, scores, and financial health for Tilray Brands, Inc.

Overview of Tilray Brands, Inc.

TLRY NMS
Healthcare Drug Manufacturers - Specialty & Generic Framework: Pharma / Mature Biotech Small Cap
Tilray Brands, Inc. (TLRY), is a Small Cap company, in the Drug Manufacturers - Specialty & Generic industry, last closed at $4.24, about 0.0% overvalued vs fair value, -30.5% 1Y return, ranked 596/1145 in sector.
Metrics Rev Growth 4.1% ROE -88.3% Gross Margin 29.3% Div Yield 0.29%
USD 4.24
0.24%
(Delayed)
• Vol 90d: 54.1%
52-Week Range
Market Cap
$523.65M
Enterprise Value
$636.11M
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Good
Health
Fair
Efficiency
Fair
Valuation
Weak
Growth
Fair
Profitability
Good
Health
Fair
Efficiency
Fair
Valuation
Weak
Completeness: 82%
Confidence: 85%
Updated: Jul 5
Top Beats

Quick Facts

Website https://www.tilray.com
HQ Leamington, ON
Employees 2,842
Fiscal year May 31

Next Events

No upcoming events available.

Fair Value Snapshot

Bear Base Bull
$-17
$-16
$-15
Current: $4.24

Engine Room Money Flow™

Small Cap

Pharmaceutical / Mature Biotech - Where revenue goes and how value is created

Flow Steps
Total Revenue
$821.3M
4.1%%
Gross Profit
$240.6M
7.7%%
R&D Expense
$284.0K
-55.3%%
Operating Income (EBIT)
$-2.3B
-1031.9%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Pharmaceutical / Mature Biotech

Quality & Reliability Indicators

R&D Intensity
0.0%
Fair

Lower R&D intensity - may indicate mature portfolio or cost cuts

Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$1.5M

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
3
Active Leaks
0/3
Improving
0
High Impact
3
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating Tilray Brands, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
35
/100
Developing
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Developing
39
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 91% Coverage
Trade-Off Triangle Visualization A ternary plot showing TLRY's balance between Growth (37.0%), Profitability (20.3%), and Safety (42.7%). Growth 37% Safety 43% Profitability 20%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

38th percentile vs peers
38
Key Signals
Revenue CAGR 3Y 9.3% 64p Rev Growth YoY 4.1% 47p TSR -76.4% 15p EPS Growth YoY -5.76 4p
Strengths
  • Debt/FCF Ratio in top 20% of peers (-2.58, 87th percentile)
Risks
  • EPS Growth YoY in bottom 20% of peers (-5.76)

Profitability

21th percentile vs peers
21
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

44th percentile vs peers
44
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Tilray Brands, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$-16.25
- - -
- upside
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000